NDC 52544-152

RAPAFLO

Silodosin

RAPAFLO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Silodosin.

• Product ID: 52544-152_01d2cfa3-9fd9-44ef-91db-71e5800d838d
• NDC: 52544-152
• Product Type: Human Prescription Drug
• Proprietary Name: RAPAFLO
• Generic Name: Silodosin
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2009-03-23
• Marketing End Date: 2020-02-29
• Marketing Category: NDA / NDA
• Application Number: NDA022206
• Labeler Name: Actavis Pharma, Inc.
• Substance Name: SILODOSIN
• Active Ingredient Strength: 8 mg/1
• Pharm Classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
• NDC Exclude Flag: N

Packaging

NDC 52544-152-19

90 CAPSULE in 1 BOTTLE, UNIT-DOSE (52544-152-19)

• Marketing Start Date: 2009-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 52544-152-19 [52544015219]

RAPAFLO CAPSULE

• Marketing Category: NDA
• Application Number: NDA022206
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-03-23
• Marketing End Date: 2020-02-29

NDC 52544-152-30 [52544015230]

RAPAFLO CAPSULE

• Marketing Category: NDA
• Application Number: NDA022206
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-03-23
• Marketing End Date: 2020-02-29

NDC 52544-152-10 [52544015210]

RAPAFLO CAPSULE

• Marketing Category: NDA
• Application Number: NDA022206
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-03-23
• Marketing End Date: 2012-12-20

NDC 52544-152-00 [52544015200]

RAPAFLO CAPSULE

• Marketing Category: NDA
• Application Number: NDA022206
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-03-23
• Marketing End Date: 2009-03-23

Drug Details

Active Ingredients

Ingredient	Strength
SILODOSIN	8 mg/1

OpenFDA Data

• SPL SET ID: a21163d6-e1b9-4490-bce3-751e0823797c
• Manufacturer:
  • Actavis Pharma, Inc.
• UNII:
  • CUZ39LUY82
• RxNorm Concept Unique ID - RxCUI:
  • 809481
  • 826614
  • 826612
  • 809477
• UPC Code:
  • 0352544152197
  • 0352544151305
  • 0352544152302

Pharmacological Class

• Adrenergic alpha-Antagonists [MoA]
• alpha-Adrenergic Blocker [EPC]

Medicade Reported Pricing

52544015230 RAPAFLO 8 MG CAPSULE

Pricing Unit: EA | Drug Type:

52544015219 RAPAFLO 8 MG CAPSULE

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "RAPAFLO" or generic name "Silodosin"

NDC	Brand Name	Generic Name
0023-6142	RAPAFLO	silodosin
0023-6147	RAPAFLO	silodosin
52544-151	RAPAFLO	silodosin
52544-152	RAPAFLO	silodosin
0781-2623	Silodosin	Silodosin
0781-2624	Silodosin	Silodosin
27241-144	Silodosin	Silodosin
27241-145	Silodosin	Silodosin
31722-635	Silodosin	Silodosin
31722-636	Silodosin	Silodosin
33342-384	Silodosin	Silodosin
33342-385	Silodosin	Silodosin
42291-777	Silodosin	Silodosin
42291-778	Silodosin	Silodosin
46708-405	Silodosin	Silodosin
46708-406	Silodosin	Silodosin
59651-095	SILODOSIN	SILODOSIN
59651-096	SILODOSIN	SILODOSIN